Cheryl has lived with Type 1 Diabetes for more than 40 years. She has worked as a Credentialled Diabetes Educator for over 25 years. Her interests include Diabetes Technologies, Diabetes In Pregnancy, Diabetes in the Elderly and Health Professional Education. Cheryl is manager of the Endocrinology and Diabetes Services at Western Health in Melbourne, Victoria, Australia.

Leon Tribe is a passionate diabetes advocate and active researcher in diabetes technologies and management. His online writing focusses on providing clear explanations to people with diabetes on the disease, the latest research and innovations, and its management. His advocacy and passion have been recognised by his acceptance into both the Diabetes Australia Community Advisory Council, and the Australasian Type 1 Diabetes Immunotherapy Collaborative (ATIC) Community Engagement Panel. Leon has been published in The Lancet and Diabetes Management Journal, and regularly presents at international diabetes conferences, such as ATTD.

Cheryl has lived with Type 1 Diabetes for more than 40 years. She has worked as a Credentialled Diabetes Educator for over 25 years. Her interests include Diabetes Technologies, Diabetes In Pregnancy, Diabetes in the Elderly and Health Professional Education. Cheryl is manager of the Endocrinology and Diabetes Services at Western Health in Melbourne, Victoria, Australia.

Gordon Bunyan has lived with T1D for over 50 year and for all of that time has been active in diabetes member and research organisations in Australia, and internationally as Chair of the IDF Western Pacific Region, Vice President of International Diabetes Federation and as an initial director of Life For A Child (USA). Today he is a director of Diabetes Australia, Deputy Chair, Programme Committee for the IDF-WPR Australasian Diabetes Congress 2026 and the Kellion Victory Medal Ambassador in Australia. He is a strong advocate for people with diabetes, working to ensure organisations put people with diabetes first. And, by racing classic sports cars in his spare time, demonstrates that the things other people think we should NOT do are always possible.

Alicia Jenkins is adult endocrinologist and researcher. Her interests include the prediction and prevention of diabetes complications, lipids, and technology use in diabetes care. She is the International Diabetes Federation (IDF) Chair (2025-27), on various IDF committees and President of the Diabetes NGO Insulin For Life.

Renza Scibilia has lived with type 1 diabetes since 1998. She is a diabetes advocate and activist, and is Senior Director of Global Responsibility at Breakthrough T1D (formerly JDRF). She has worked for diabetes organisations for the last twenty-five years, promoting a person-centred approach to the development, design and delivery of diabetes technologies, services, resources, research and education programs. Renza is also the Global Head of Advocacy for #dedoc°, a European-based organisation which provides opportunities for diabetes advocates from across the world to become part of a peer network and attend professional conferences under the banner #NothingAboutUsWithoutUs. Renza has extensive experience as a consultant, facilitator, presenter, and media spokesperson and is frequently invited to speak at conferences where she speaks about topics including the role of peer support in healthcare, diabetes technology and digital solutions, why language and communication matters in healthcare and how to reduce diabetes-related stigma. Renza is the author of Diabetogenic, (www.diabetogenic.wordpress.com) and a regular contributor to many online and print health publications.

Dr. Made Ratna Saraswati is an internist and endocrinologist based at Prof. Dr. I G.N.G. Ngoerah General Hospital, Bali, Indonesia, and a faculty member at the Faculty of Medicine, Udayana University. Her clinical and academic work focuses on comprehensive diabetes care, cardiometabolic health, and healthy aging. She is actively involved in community education activities to improve diabetes awareness and self-management, with a particular interest in women’s health, including the impact of menopause on metabolic and cardiovascular risk.